DE602004026684D1 - Injizierbare flüssige formulierung von paracetamol - Google Patents

Injizierbare flüssige formulierung von paracetamol

Info

Publication number
DE602004026684D1
DE602004026684D1 DE602004026684T DE602004026684T DE602004026684D1 DE 602004026684 D1 DE602004026684 D1 DE 602004026684D1 DE 602004026684 T DE602004026684 T DE 602004026684T DE 602004026684 T DE602004026684 T DE 602004026684T DE 602004026684 D1 DE602004026684 D1 DE 602004026684D1
Authority
DE
Germany
Prior art keywords
paracetamol
liquid formulation
injectable liquid
solution
antipyretic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004026684T
Other languages
English (en)
Inventor
Tho Nguyen-Xuan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32749656&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602004026684(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Publication of DE602004026684D1 publication Critical patent/DE602004026684D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Materials For Medical Uses (AREA)
DE602004026684T 2003-02-14 2004-02-16 Injizierbare flüssige formulierung von paracetamol Expired - Lifetime DE602004026684D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0301972A FR2851164B1 (fr) 2003-02-14 2003-02-14 Formulation liquide injectable de paracetamol
PCT/CH2004/000085 WO2004071502A1 (fr) 2003-02-14 2004-02-16 Formulation liquide injectable de paracetamol

Publications (1)

Publication Number Publication Date
DE602004026684D1 true DE602004026684D1 (de) 2010-06-02

Family

ID=32749656

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004026684T Expired - Lifetime DE602004026684D1 (de) 2003-02-14 2004-02-16 Injizierbare flüssige formulierung von paracetamol

Country Status (13)

Country Link
US (1) US8071619B2 (de)
EP (1) EP1592414B1 (de)
JP (1) JP4861162B2 (de)
CN (1) CN100546574C (de)
AT (1) ATE464891T1 (de)
AU (1) AU2004212269B2 (de)
CA (1) CA2517491C (de)
DE (1) DE602004026684D1 (de)
EA (1) EA008908B1 (de)
ES (1) ES2344697T3 (de)
FR (1) FR2851164B1 (de)
MA (1) MA27748A1 (de)
WO (1) WO2004071502A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005037653A1 (de) 2005-08-05 2007-02-15 Theraselect Gmbh Stabile, flüssige Formulierung von Paracetamol
US9943479B2 (en) * 2006-07-18 2018-04-17 Genfarma Laboratorio S.L. Injectable liquid paracetamol formulation
EP1992334A1 (de) * 2007-05-08 2008-11-19 Docpharma NV/SA Lagerfähige Formulierung eines oxidationsempfindlichen phenolhaltigen Arzneimittels, insbesondere Paracetamol, mit einer wässrigen, durch ein temperaturgeregeltes Herstellungsverfahren desoxidierten Arzneimittellösung
EP2170313A2 (de) * 2007-06-18 2010-04-07 Combino Pharm, S.L. Wässrige formulierungen aus acetaminophen zur injektion
WO2009081283A2 (en) * 2007-06-18 2009-07-02 Combino Pharm, S.L. Aqueous formulations of acetaminophen for injection
CA2705733C (en) 2007-11-13 2015-02-03 Cadence Pharmaceuticals Reduced dose intravenous acetaminophen
US20110015273A1 (en) * 2008-01-17 2011-01-20 Rajnarayana Kandhagatla Stable pharmaceutical aqueous compositions
FR2926992B1 (fr) * 2008-02-06 2011-01-14 Moly Pharma Formulation d'une solution de paracetamol injectable,procede de preparation et de conditionnement d'une telle solution et dispositif de conditionnement d'une telle solution
ES2321906B1 (es) * 2008-11-28 2010-02-09 Laboratorios Normon, S.A. Composicion farmaceutica que comprende una solucion acuosa de paracetamol.
EP2243477A1 (de) 2009-04-22 2010-10-27 Fresenius Kabi Deutschland GmbH Paracetamol zur parenteralen Verabreichung
US20110207824A1 (en) * 2010-02-25 2011-08-25 Moly Pharma Formulation of an injectable paracetamol solution, method for preparing and packaging such a solution and device for packaging such a solution
EP2377516B1 (de) 2010-04-14 2012-06-20 B. Braun Melsungen AG Acetaminophenzusammensetzung
EP2389923B1 (de) * 2010-05-19 2013-01-30 Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. Stabile, gebrauchsfertige, injizierbare Paracetamolformulierung
ES2414557B1 (es) 2012-01-16 2014-06-10 Novocat Farma, S.A. Composición acuosa de paracetamol para inyección
ITMI20121154A1 (it) 2012-06-29 2013-12-30 Sint Sa Soluzione iniettabile di acetaminofene per la somministrazione spinale
US20140303254A1 (en) * 2013-04-08 2014-10-09 InnoPharma Licensing LLC Process Of Manufacturing A Stable, Ready To Use Infusion Bag For An Oxidation Sensitive Formulation
BR102014005885B1 (pt) 2014-03-13 2021-04-13 Biotec Biológica Indústria Farmacêutica Ltda E.P.P Formulação farmacêutica líquida injetável estável de paracetamol em bolsa plástica pronta para uso
CN108289869B (zh) * 2014-04-28 2021-08-27 奥佛麦德公司 使用通过酚羟基连接的药学活性的对乙酰氨基酚二聚体治疗疼痛的方法
CN110642677B (zh) * 2019-08-30 2023-05-26 浙江工业大学 双芳基衍生物的制备、双芳基衍生物及应用
CN112782332A (zh) * 2021-02-04 2021-05-11 深圳市药品检验研究院（深圳市医疗器械检测中心） 一种对乙酰氨基酚药品中对氨基酚杂质的hplc检测方法
CN114965754B (zh) * 2022-05-13 2024-04-09 陕西必康制药集团控股有限公司 对乙酰氨基酚片中有关物质及抑菌剂的检测方法
CN115385818B (zh) * 2022-09-01 2023-09-29 江苏海洋大学 一种扑热息痛杂质及制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS545022A (en) * 1977-06-14 1979-01-16 Zenyaku Kogyo Kk Production of solution agent containing aqueous licorice extract and acetoaminophenone
AU573321B2 (en) 1984-03-14 1988-06-02 Jerome Corbiere Process for solubilizing active principles and pharmaceuticalcompositions thus obtained
FR2751875B1 (fr) * 1996-08-05 1998-12-24 Scr Newpharm Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation
ATE329621T1 (de) * 1997-11-18 2006-07-15 Uni Pharma Kleon Tsetis Pharmaceutical Lab Sa Pharmazeutische injizierbare lösungen, die paracetamol und kombinationen aus paracetamol mit anderen aktivsubstanzen enthalten
IT1301976B1 (it) 1998-07-31 2000-07-20 Angelini Ricerche Spa Composizione farmaceutica iniettabile a base di paracetamolo
FR2809619B1 (fr) 2000-06-06 2004-09-24 Pharmatop Nouvelles formulations aqueuses de principes actifs sensibles a l'oxydation et leur procede d'obtention
DE10112325A1 (de) * 2001-03-13 2002-10-02 Fresenius Kabi De Gmbh Lagerstabile Fertiginfusionslösungen des Paracetamols
ITMI20012135A1 (it) * 2001-10-16 2003-04-16 Bioren S A Soluzioni iniettabili pronte all'uso di paracetamolo

Also Published As

Publication number Publication date
EA008908B1 (ru) 2007-08-31
EP1592414A1 (de) 2005-11-09
CA2517491C (fr) 2012-07-31
FR2851164B1 (fr) 2005-04-22
FR2851164A1 (fr) 2004-08-20
AU2004212269B2 (en) 2009-05-28
WO2004071502A1 (fr) 2004-08-26
US20060084703A1 (en) 2006-04-20
CA2517491A1 (fr) 2004-08-26
JP4861162B2 (ja) 2012-01-25
CA2517491E (fr) 2004-08-26
CN100546574C (zh) 2009-10-07
AU2004212269A1 (en) 2004-08-26
EA200501302A1 (ru) 2006-04-28
JP2006517544A (ja) 2006-07-27
ES2344697T3 (es) 2010-09-03
MA27748A1 (fr) 2006-02-01
EP1592414B1 (de) 2010-04-21
US8071619B2 (en) 2011-12-06
ATE464891T1 (de) 2010-05-15
CN1750818A (zh) 2006-03-22

Similar Documents

Publication Publication Date Title
MA27748A1 (fr) Formulation liquide injectable de paracetamol
NO2017028I2 (no) eftrenonacog alfa eller et biotilsvarende legemiddel ihht Artikkel 10(4) av Directive 2001/83/EC, som beskyttet av basispatentet.
EA200702683A1 (ru) Устройство и способ для инъекций
EA201070121A1 (ru) Лекарственная форма, содержащая слитый белок glp-1-fc
ATE320815T1 (de) Verwendung einer neurotoxintherapie zur behandlung von prostata erkrankungen
ATE254928T1 (de) Stabilisierte zusammensetzung mit nootropen wirkstoffen
ATE429243T1 (de) G-csf-flüssigformulierung
ATE430589T1 (de) Wasserbehandlung zur kontrolle von biobewuchs mittels stabilisierter bromlösungen
CY1107707T1 (el) Αναστολεις της φωσφοδιεστερασης-5 για την προφυλαξη και/ή τη θεραπεια της πυλαιας υπερτασης
DE60224449D1 (de) Gebrauchsfertige paracetamol injektionslösungen enthaltend propylenglykol als einziges cosolvens
DE60116642D1 (de) Verbindungen mit cytochrom p450ra1 hemmenden aktivität
ATE441704T1 (de) Varianten eines lipolytischen enzyms
RU2009103818A (ru) Водная лекарственная композиция 4-[(4-карбоксибутил)-{2-[(4-фенетилбензил)окси)-фенетил}амино)метил)-бензойной кислоты
ATE240267T1 (de) Erzeugung von gebrauchsfertigen lösungen
NO20045437L (no) Medikamenter for behandling av akutte dysfunksjoner i portavenesirkulasjon og hepatisk sirkulasjon
PE50296A1 (es) Eter substituido con tiazol y oxazol biciclico
DE60306344D1 (de) Behandlung von typ i diabetes mellitus mit wachstumshormonantagonisten
ITMI20041871A1 (it) Uso di santoreggia satureja montana o dei suoi estratti per la preparazione di medicamenti per il trattamento dell'eiaculazione precoce
苑广凤 I Like Winter
RU2004103180A (ru) Способ лечения хронических диффузных заболеваний печени применением курса внутривенных инфузий растворов гипохлорита натрия
RU2001132208A (ru) Способ термохимической обработки призабойной зоны пласта
ES2179763B1 (es) Nueva formulacion desinfectante y conservante, procedimiento para su preparacion y sus aplicaciones.
EA200000168A1 (ru) Фармацевтическая композиция, снижающая продуцирование белка мср-1
Van Meerbeek et al. Bonding effectiveness of one-step self-etch adhesives to enamel and dentin
ATE397939T1 (de) Stabilisierte flüssigzubereitung der den blutgerinnungsfaktor vii aktivierenden protease oder ihres proenzyms

Legal Events

Date Code Title Description
8363 Opposition against the patent